Nur Nicholson, Chief Technical Officer at Apellis Pharmaceuticals, Inc. (APLS), sold 40,700 shares at $42.21 ($1.8M) on 2023-09-18, disclosed to the SEC on 2023-09-19.
Open-market sale of $1.8M APLS by Chief Technical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.21 | 9,719 | $410K | 22.8% |
| 2 | $42.21 | 9,719 | $410K | 22.8% |
| 3 | $46.15 | 10,631 | $491K | 27.2% |
| 4 | $46.15 | 10,631 | $491K | 27.2% |
| Total | $44.27 avg | 40,700 | $1.8M | 100% |
| Filing → |
| APLS | SELL | 2026-01-15 | $58K | — | Filing → |
| APLS | SELL | 2025-01-30 | $24K | — | Filing → |
| APLS | SELL | 2025-01-23 | $240K | — | Filing → |